PMID: 9168221May 1, 1997Paper

Emery A. Rovenstine and regional anesthesia

Regional Anesthesia
D R Bacon, H Darwish

Abstract

Emery Andrew Rovenstine was a dominant figure in anesthesiology in the United States between 1935 and 1960. Among his many contributions to the specialty, his regional anesthesia practice remains less well known. This paper explores Rovenstine's career and his contributions to regional anesthesia. Original documents studied and classified for this investigation included all of Rovenstine's published papers and the extant documents of the original American Society of Regional Anesthesia. Interviews with several physicians who knew Rovenstine were conducted. Secondary source materials, including biographies of Rovenstine, were perused. Rovenstine made a major contribution to regional anesthesia through patient care, teaching, and political action. Many of his students went on to become leaders in anesthesiology and emphasized regional anesthesia in the second half of the twentieth century. Emery A. Rovenstine did much to popularize regional anesthesia and ensure a rightful place for its techniques within the armamentarium of the anesthesiologist. Keeping alive the traditions of Gaston Labat at Bellevue, Rovenstine's contributions to regional anesthesia on all levels were considerable. Most importantly, he ensured an enduring role...Continue Reading

Citations

Oct 25, 2017·Regional Anesthesia and Pain Medicine·Shelly B Borden, Colby L Parks
Sep 24, 2011·Regional Anesthesia and Pain Medicine·Michael F Mulroy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.